How parathyroid hormone affects fat metabolism in bone health
Parathyroid hormone (PTH) modulates lipid metabolism in the skeletal niche
This study is looking at how a hormone called intermittent parathyroid hormone (iPTH) can help improve bone health by affecting fat cells in the bone, which could lead to better treatments for osteoporosis and osteopenia, helping people strengthen their bones with fewer side effects.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11326030 on NIH RePORTER |
What this research studies
This research investigates the role of intermittent parathyroid hormone (iPTH) in enhancing bone health by modulating lipid metabolism in the skeletal environment. The study focuses on understanding how iPTH influences fat cells in the bone marrow and promotes the use of lipids by bone-forming cells, known as osteoblasts. By exploring these mechanisms, the research aims to develop improved treatments for osteoporosis and osteopenia, conditions that weaken bones and increase fracture risk. Patients may benefit from new therapeutic options that minimize side effects while effectively promoting bone formation.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are at risk for or suffering from osteoporosis or osteopenia.
Not a fit: Patients with conditions unrelated to bone health or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for osteoporosis that enhance bone health with fewer side effects.
How similar studies have performed: Previous research has shown promising results in using parathyroid hormone for bone health, indicating that this approach has potential for success.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Rendina-Ruedy, Elizabeth — Vanderbilt University Medical Center
- Study coordinator: Rendina-Ruedy, Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.